PCT & Support

Arimidyn 0.5 mg Driada Medical

Driada Medical

45,00

In Stock (100 available)

Arimidyn 0.5 mg Driada Medical (0.5 mg) — Effective estrogen management is the difference between a successful steroid cycle and one plagued by water retention, gynecomasti…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Arimidyn 0.5 mg Driada Medical — Effective estrogen management is the difference between a successful steroid cycle and one plagued by water retention, gynecomastia, and fat gain. Anastrozole provides that management with pharmaceutical precision, reducing estradiol levels in a dose-dependent manner while maintaining enough estrogen for cardiovascular and joint health. This formulation is dosed at 0.5 mg per unit.

Key Benefits

  • Aromatase inhibitor — blocks oestrogen synthesis at the source
  • Standard on-cycle AI for testosterone-based protocols
  • Low dose (0.25–0.5 mg EOD) typically sufficient for 400–500 mg test
  • Dose by bloodwork — sensitive E2 assay, target 20–40 pg/mL
  • Crashing E2 feels worse than mildly elevated E2 — err on the low side
  • Each unit dosed at 0.5 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 0.25–0.5 mg every other day on testosterone-based cycles. Titrate to bloodwork (sensitive E2 assay, target 20–40 pg/mL). Higher doses required only on aggressive 700+ mg/week test protocols. During PCT: not used (blocks oestrogen needed for LH signalling).

How It Works

Non-steroidal aromatase inhibitor. Binds and inactivates the aromatase enzyme (CYP19A1) that converts testosterone and androstenedione to estradiol and estrone. Reversible binding — effect disappears within days of stopping.

Pharmacokinetics

Plasma half-life approximately 50 hours. Every-other-day dosing produces stable serum and tissue levels. Steady-state in 7 days.

Cycle & Stacking Guide

Used on-cycle with aromatising compounds (testosterone, methandienone, oxymetholone). Start at 0.25 mg EOD, bloodwork at week 4, adjust. Never used during PCT — needed estrogen signalling for LH/FSH recovery.

Manufacturer Notes

Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code; batch COAs available through the distributor.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Arimidyn 0.5 mg Driada Medical”

Your email address will not be published. Required fields are marked *